Watchlist Price Alert

Akebia Therapeutics Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

3.54

-0.04 (-1.12%)

At close: Jun 17, 2025, 10:53 AM

Akebia Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	51.87M	42.92M	90.47M	149.8M	228.7M	147.45M	104.64M	70.16M	187.34M
Short-Term Investments	n/a	n/a	n/a	n/a	39.99M	245K	217M	247.64M	73.01M
Long-Term Investments	n/a	n/a	2.7M	2.04M	2.04M	2.09M	2.46M	1.28M	n/a
Other Long-Term Assets	37.38M	12.42M	5.37M	49.75M	37.98M	75.98M	21.8M	2.27M	1.28M
Receivables	34.37M	39.29M	41.06M	51.58M	26.85M	38.86M	16.67M	34.22M	33.82M
Inventory	16.24M	15.69M	21.76M	38.2M	61.02M	116.35M	114.25M	n/a	n/a
Other Current Assets	7.32M	20.24M	17.25M	4.31M	n/a	263K	15.72M	6.35M	n/a
Total Current Assets	113.83M	118.15M	184.95M	272.01M	371.44M	309.53M	468.27M	358.36M	296.32M
Property-Plant & Equipment	10.42M	16.05M	34.37M	40.61M	35.5M	39.42M	8.02M	3.62M	2.61M
Goodwill & Intangibles	59.04M	95.09M	127.14M	163.18M	199.22M	346.26M	383.21M	-1.46M	n/a
Total Long-Term Assets	106.84M	123.55M	166.88M	253.54M	272.7M	461.67M	528.26M	5.89M	3.9M
Total Assets	220.67M	241.7M	351.83M	525.55M	644.14M	771.2M	996.54M	364.25M	300.22M
Account Payables	15.18M	14.63M	18.02M	33.59M	41.31M	39.22M	42.8M	7M	2.04M
Deferred Revenue	n/a	n/a	3.74M	20.91M	15.21M	39.83M	56.98M	84.91M	81.97M
Short-Term Debt	n/a	19.55M	32M	97.54M	n/a	n/a	15M	n/a	n/a
Other Current Liabilities	56.54M	18.26M	52.53M	31.18M	38.05M	31.28M	26.82M	46.47M	29K
Total Current Liabilities	80.91M	99.87M	124.76M	256.49M	187.15M	208.12M	265.69M	144.35M	114.27M
Long-Term Debt	38.69M	71.2M	91.56M	n/a	96.38M	75.81M	n/a	n/a	n/a
Other Long-Term Liabilities	146.7M	48.98M	57.47M	139.11M	63.03M	31.87M	32.58M	2.61M	2.51M
Total Long-Term Liabilities	188.94M	172.42M	217.73M	192.6M	209.38M	168.33M	94.92M	100.57M	117.83M
Total Liabilities	269.86M	272.29M	342.49M	449.09M	396.52M	376.44M	360.61M	244.92M	232.1M
Total Debt	47.64M	104.18M	99.78M	136.05M	126.28M	108.32M	15M	n/a	14K
Common Stock	2K	2K	2K	1K	1K	1K	1K	n/a	n/a
Retained Earnings	-1.68B	-1.61B	-1.55B	-1.46B	-1.18B	-794.05M	-514.39M	-374.05M	-297.14M
Comprehensive Income	6K	6K	6K	6K	13K	0.00	-261K	-442K	-42K
Shareholders Equity	-49.19M	-30.58M	9.34M	76.46M	247.62M	394.76M	635.93M	119.33M	68.12M
Total Investments	n/a	1.65M	2.7M	2.04M	39.99M	245K	217M	247.64M	73.01M